Health

Ema launches review of Pflovid, Pfizer’s anti-Covid drug

ADVERTISING
Rome, 23 November – The European Medicines Agency announced last Friday, 19 November, the launch of a review for Paxlovid, the Pfizer pill against Covid. The EMA says it has begun reviewing the data currently available on the drug, which should represent a step forward on the home care front, and has begun reviewing it. “To support national authorities who could decide on its timely use, for example in emergencies, before the marketing authorization.”

ADVERTISING

ADVERTISING
1 of 7